Advertisement

Bariatric Surgery and Cancer

  • Yaniv Fenig
  • Ronald Matteotti
Chapter

Abstract

The Centers for Disease Control and Prevention (CDC) has recently reported the prevalence of obesity, defined as a BMI ≥ 30, within the adult population in the USA to be 36.5%. These numbers have been steadily growing since the 1960s. Obesity is higher in females than in males, middle-aged and older than younger adults, white, black, and Hispanic than Asian adults. Obesity has a major impact on the global health and contributes to many other disease processes, like cancer. Bariatric surgery seems to have a protective effect on the incidence of cancer and the overall mortality. This holds especially true for hormonal-driven cancers, like breast, as well as for cancers where inflammation is a major precursor.

Keywords

Cancer Bariatric surgery Obesity Cancer incidence Mortality Morbidity 

References

  1. 1.
    Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015;219(219):1–8.Google Scholar
  2. 2.
    Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA. The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int J Obes Relat Metab Disord. 1996;20(1):63–75.Google Scholar
  3. 3.
    Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure: findings in hypertension screening of 1 million Americans. JAMA. 1978;240(15):1607–10.CrossRefPubMedGoogle Scholar
  4. 4.
    Medalie JH, Papier CM, Goldbourt U, Herman JB. Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med. 1975;135(6):811–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–77.CrossRefPubMedGoogle Scholar
  6. 6.
    Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55(3):652–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Hart DJ, Spector TD. The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford study. J Rheumatol. 1993;20(2):331–5.PubMedGoogle Scholar
  9. 9.
    Loube DI, Loube AA, Mitler MM. Weight loss for obstructive sleep apnea: the optimal therapy for obese patients. J Am Diet Assoc. 1994;94(11):1291–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Chute CG, Willett WC, Colditz GA, Stampfer MJ, Baron JA, Rosner B, Speizer FE. A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women. Cancer Causes Control. 1991;2(2):117–24.CrossRefPubMedGoogle Scholar
  11. 11.
    Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122(5):327–34.CrossRefPubMedGoogle Scholar
  12. 12.
    Marchand L, Wilkens LR, Mi MP. Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control. 1992;3(4):349–54.CrossRefPubMedGoogle Scholar
  13. 13.
    Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis. 1979;32(8):563–76.CrossRefPubMedGoogle Scholar
  14. 14.
    Kim MK, Reaven GM, Chen YD, Kim E, Kim SH. Hyperinsulinemia in individuals with obesity: role of insulin clearance. Obesity. 2015;23(12):2430–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Watkins LF, Lewis LR, Levine AE. Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer. 1990;45(2):372–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Sinicrope FA, Foster NR, Sargent DJ, O’Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010;16(6):1884–93.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Rapp K, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Schroeder J. Weight change and cancer risk in a cohort of more than 65 000 adults in Austria. Ann Oncol. 2008;19(4):641–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Willett WC, Browne ML, Bain C, Lipnick RJ, Stampfer MJ, Rosner B, Colditz GA, Hennekens CH, Speizer FE. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol. 1985;122(5):731–40.CrossRefPubMedGoogle Scholar
  19. 19.
    Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278(17):1407–11.CrossRefPubMedGoogle Scholar
  20. 20.
    Schottenfeld D, Fraumeni Jr JF. Cancer epidemiology and prevention. Oxford University Press, New York; 2006.Google Scholar
  21. 21.
    Marmot M, Diet, cancer, and NCD prevention. Lancet Oncol. 2018. pii: S1470-2045(18)30382-6.Google Scholar
  22. 22.
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.CrossRefPubMedGoogle Scholar
  23. 23.
    Polednak AP. Estimating the number of US incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev. 2008;32(3):190–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, Buchan I. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer. 2010;126(3):692–702.CrossRefPubMedGoogle Scholar
  25. 25.
    Higgins M, D’Agostino R, Kannel W, Cobb J. Benefits and adverse effects of weight loss: observations from the Framingham study. Ann Intern Med. 1993;119(7_Part_2):758–63.CrossRefPubMedGoogle Scholar
  26. 26.
    Angrisani L, Cutolo PP, Formisano G, Nosso G, Vitolo G. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Relat Dis. 2013;9(3):405–13.CrossRefPubMedGoogle Scholar
  27. 27.
    Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86.CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, LaMonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.CrossRefPubMedGoogle Scholar
  29. 29.
    Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRefPubMedGoogle Scholar
  30. 30.
    Sjöström L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, Wedel H, Bengtsson C, Bouchard C, Carlsson B, Dahlgren S, Jacobson P. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.CrossRefPubMedGoogle Scholar
  31. 31.
    Zhou X, Yu J, Li L, Gloy VL, Nordmann A, Tiboni M, Li Y, Sun X. Effects of bariatric surgery on mortality, cardiovascular events, and cancer outcomes in obese patients: systematic review and meta-analysis. Obes Surg. 2016;26(11):2590–601.CrossRefPubMedGoogle Scholar
  32. 32.
    Hofsø D, Nordstrand N, Johnson LK, Karlsen TI, Hager H, Jenssen T, Bollerslev J, Godang K, Sandbu R, Røislien J, Hjelmesæth J. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163(5):735–45.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Arterburn D, Bogart A, Coleman KJ, Haneuse S, Selby JV, Sherwood NE, Sidney S, Theis MK, Campos GM, McCulloch D, O’Connor PJ. Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013;7(4):e258–68.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Derogar M, Hull MA, Kant P, Östlund M, Lu Y, Lagergren J. Increased risk of colorectal cancer after obesity surgery. Ann Surg. 2013;258(6):983–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Christou NV, Lieberman M, Sampalis F, Sampalis JS. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4(6):691–5.CrossRefPubMedGoogle Scholar
  36. 36.
    Ikramuddin S, Billington CJ, Lee WJ, Bantle JP, Thomas AJ, Connett JE, Leslie DB, Inabnet WB, Jeffery RW, Chong K, Chuang LM. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol. 2015;3(6):413–22.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Halperin F, Ding SA, Simonson DC, Panosian J, Goebel-Fabbri A, Wewalka M, Hamdy O, Abrahamson M, Clancy K, Foster K, Lautz D. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7):716–26.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Koehestanie P, de Jonge C, Berends FJ, Janssen IM, Bouvy ND, Greve JW. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg. 2014;260(6):984–92.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Monmouth Medical CenterLong BranchUSA
  2. 2.The HOPE Tower at Jersey Shore University Medical CenterNeptuneUSA
  3. 3.Hepatobiliary and Pancreatic Program Meridian Cancer CareNeptuneUSA
  4. 4.Hepatobiliary and Pancreatic Surgery JSUMCNeptuneUSA

Personalised recommendations